Reply from chairman of BMA's medical ethics committee

doi:10.1136/bmj.313.7070.1477a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

J Stuart Horner

Chairman, BMA medical ethics committee Beth Shemesh, Spring Lane, Samlesbury, Preston PR5 0UX

EDITOR,—The issue on which the BMA has focused in the recent controversy is the principle of informed and considered consent. We looked beyond the case in hand to its potential impact on one of the cornerstones of medical practice, being profoundly aware that the final result may set precedents regarding the extraction and use of genetic material from dying or dead people. A letter was sent to the Human Fertilisation and Embryology Authority because aspects of …